phase readout

NCT03295227: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

RECRUITINGupdated 2mo ago

community read0 votes

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8, Stage IIIB Thymoma AJCC v8, Stage IV Thymoma AJCC v8, Stage IVA Thymoma AJCC v8, Stage IVB Thymoma AJCC v8, Unresectable Thymic Carcinoma

view source ↗

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ctgov

last refreshed 4h ago

Found something off?